BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Business

  AbbVie Abandons Arthritis Pact With Ablynx

  October 20, 2016

   · 

  3 min read
• 

  Genetown

  Why This 27-Employee Biotech is Outperforming Every Public Massachusetts Company This Year

  October 20, 2016

   · 

  2 min read
• 

  FDA

  Sarepta Gets No Love From the FDA’s New Drugs Director

  October 20, 2016

   · 

  3 min read
• BioCapital

  It Looks As Though There’s Only One Thing Big Drug Companies Are Afraid Of

  October 20, 2016

   · 

  1 min read
• Biotech Beach

  Organovo Prices Approximately $25 Million Public Offering Of Common Stock

  October 20, 2016

   · 

  5 min read
• Drug Development

  HedgePath Pharmaceuticals Announces Further Positive Interim Data In Its Phase II(B) Cancer Trial

  October 20, 2016

   · 

  8 min read
• Drug Development

  Theravance Biopharma And Mylan Announce Positive Results From Two Pivotal Phase 3 Studies Of Revefenacin (TD-4208) For The Treatment Of Chronic Obstructive Pulmonary Disease (COPD)

  October 20, 2016

   · 

  15 min read
• Drug Development

  MicuRx Pharma Initiates Phase 3 Clinical Trial for MRX-I, A New Potent Oral Antibiotic Against Gram-positive Bacteria, Including MRSA

  October 20, 2016

   · 

  4 min read
• Drug Development

  Sanifit Announces Initiation Of First Clinical Trial Of SNF472 In Patients With Calciphylaxis

  October 20, 2016

   · 

  4 min read
• Policy

  FDA Panel Backs Allergan’s Drug For Frequent Nightly Urination

  October 20, 2016

   · 

  1 min read